UNFPA, US pharma firm partner to roll out HPV vaccination in Vietnam

The United Nations Population Fund (UNFPA) and the US-based pharmaceutical company Merc Sharp & Dohme (MSD) will join hands to support the Ministry of Health to roll out the human papillomavirus (HPV) vaccination programme in Vietnam from 2019 – 2021.
UNFPA, US pharma firm partner to roll out HPV vaccination in Vietnam ảnh 1The United Nations Population Fund (UNFPA) and the US-based pharmaceutical company Merc Sharp & Dohme (MSD) will join hands to support the roll-out of the HPV vaccination programme in Vietnam from 2019 – 2021. (Photo: UNFPA)

Hanoi (VNA) – TheUnited Nations Population Fund (UNFPA) and the US-based pharmaceutical companyMerc Sharp & Dohme (MSD) will join hands to support the Ministry of Health to roll out the human papillomavirus (HPV) vaccination programme in Vietnam from 2019 – 2021.

An agreement to this effect was signed between the two sides in Hanoi on July 24.

Addressing the signingceremony, Deputy Director of the General Department of Preventive MedicineNguyen Minh Hang said vaccination is an effective and popular measure to prevent infectious diseases. Thanks to vaccines andthe national expanded immunization programme, many dangerous epidemics areeliminated or controlled, she noted.

“Evidence from international studies also confirms that a strategiccombination of sufficient coverage of HPV vaccination for adolescent girls andsufficient coverage of cervical screening and appropriate treatment for allwomen can eliminate cervical cancer as a public health problem within ourlifetime,” said Astrid Bant, UNFPA Representative in Vietnam.

MSD Vietnam ChiefRepresentative Koen Carel Kruijtbosch said developing vaccines that helpprotect public health is more than a business decision, it is a sharedmission. Every day in Vietnam, seven women die fromcervical cancer. This partnership between the UNFPA and the MSD hopes to address this disease burden, he added.

With a total budget of400,000 USD, the collaboration aims to conductevidence-based advocacy to encourage national and sub-national stakeholders toreduce the burden of HPV-related diseases and facilitate the gradualscale up of an HPV vaccination programme and the development of policies toprevent cervical cancer. 

Cervical cancer remains amajor killer of women. Caused by HPV,cervical cancer claims the lives of more than 300,000 women every year, ofwhich 85 percent live in developing countries, according to the World HealthOrganisation. –VNA
VNA

See more

A healthcare worker administers a measles vaccine to a child at a vaccination site in Hanoi. (Photo: VNA)

WHO, UNICEF commend Vietnam’s progress in childhood immunisation

In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.

Youngsters donate blood at the National Institute of Haematology and Blood Transfusion in Hanoi. (Photo courtesy of NIHBT)

Health sector calls on people to donate blood

During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.

Le Thanh Dung, Director of the Population Authority under the Ministry of Health, speaks at the meeting. (Photo: VNA)

Hanoi celebrates World Population Day

The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.

Vietnam, Germany forge cardiovascular partnership

Vietnam, Germany forge cardiovascular partnership

Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.

Patients are treated in a hyperbaric oxygen chamber at the Vietnam National Institute of Marine Medicine. (Photo: VNA)

Vietnam – attractive destination for medical tourism

Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.

Telehealth platforms in use at Hanoi Medical University Hospital. (Photo: nhandan.vn)

Vietnam looks to expand telehealth to improve access for remote communities

Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.

A doctor from the medical centre of Ward 16, Go Vap district, Ho Chi Minh City is providing an online medical examination for a patient. (Photo: VNA)

Vietnam, RoK strengthen cooperation in telemedicine

During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.